Biotech Co.*(Country; Symbol) Agbiotech Partner/Institution Type/Product Area Terms/Details(Date)
Accera Inc.* Nestle Purina PetCare Global Resources Inc. Nestle Purina got rights to develop Accera's AC-1203 for treating aging conditions in dogs and other companion animals The agent will be developed for canine cognitive dysfunction and other conditions; Accera gets an up-front payment, and is eligible to receive milestone payments (1/8)
Aureus Pharma* (France) Bayer CropScience (Germany) Licensing agreement for Aureus AurSCOPE Knowledge databases The databases contain quantitative biological activity data related to various protein targets including G-Protein Coupled receptors, ion channels and kinases, which are important in fungicide and insecticide development (4/5)
Cambria Biosciences LLC* Pfizer Animal Health (unit of Pfizer Inc.) Research collaboration to guide the discovery and development of new classes of antiparasitic drug products Cambria will use its chemical genetics plat-form to elucide the molecular targets that have responded to Pfizer's candidate para-siticidal compounds (6/7)
Chromatin Inc.* Syngenta Biotechnology Inc. (NYSE:SYT) Nonexclusive rights agreement to Chromatin's gene-stacking technology for trait genes in corn and soybeans Chromatin's novel approach to gene stacking uses a plant's own DNA to deliver several genes on a mini-chromosome (10/19)
Cibus LLC* BASF Collaboration to develop and commercialize non-GM herbicide tolerance in oilseed rape and canola Cibus' gene-conversion plant breeding technology will be used to enhance BASF's Clearfield Production System in oilseed rape and canola (7/10)
Codon Devices Inc.* Agrivida Inc.* Agreement for the discovery, development and commercial-ization of engineered proteins for biofuel applications In exchange for royalty and performance-based payments, Codon will use its Biologic Engineering Partnering Program to develop enzymes optimized for use in Agrivida's ethanol production technology (8/1)
Crucell NV(the Netherlands; CRXL) Pfizer Animal Health Pfizer got rights to use Crucell's PER.C6 cell technology in the production of a veterinary vaccine The vaccine was not disclosed; Pfizer has an option to convert the research license into a commercial license; terms were not disclosed (3/15)
Devgen NV (Belgium; BE:HNV) Monsanto Co. (NYSE:MON) Research and development agreement to explore technology applications in crop areas of interest Devgen will leverage Monsanto's work in rice and small cereal grains, especially in Asia, and Monsanto initially intends to leverage Devgen's gene regulation tech-nologies to protect against crop damage in its core crops of interest such as corn, cotton and soybeans (2/7)
Dow Agro-Sciences LLC(unit of Dow Chemical Co.; NYSE:DOW) Exelixis Plant Sciences (EXEL) Research agreement focused on the development of new tools for gene discovery and validation of novel crop traits Deal includes an asset purchase by Dow's affiliate Agrigenetics Inc. (9/5)
Evogene Ltd.(Israel; TASE:EVGN) Bayer CropScience (Germany) Collaboration to increase the productivity and yield of a Bayer CropScience core crop Bayer CropScience has exclusively licensed the rights to certain genes discovered by Evogene that have demonstrated improved plant yield and other performance enhancements; Evogene is to receive an initial fee, success-based milestone payments and royalties on sales (6/18)
Evogene Ltd.(Israel; TASE:EVGN) Monsanto Co. (NYSE:MON) Collaboration to improve nitrogen use efficiency in corn, soybeans, canola and cotton Monsanto got exclusive rights to a number of genes discovered by Evogene that are believed to help plants maintain yield with lower applications of nitrogen (9/25)
Evogene Ltd. (Israel; TASE:EVGN) Midwest Oilseeds Inc. Licensing agreement for gene transformation technologies that will allow Evogene to more efficiently validate candidate genes to improve commercial crops Terms were not disclosed (9/5)
Evogene Ltd. (Israel; TASE:EVGN) Orfuel Inc. Collaboration in the field of alternative energy and biofuels It is aimed at providing substantially improved feedstock sources for biodiesel production (9/24)
Evogene Ltd. (Israel; TASE:EVGN) Pioneer Hi-Bred Agreement for exclusive rights to several of Evogene's genes that improve drought-stress tolerance primarily in corn and soybeans Financial terms were not disclosed (10/30)
Gene-IT Inc.* Public Intellectual Property Resource for Agriculture Agreement under which Gene-IT is providing its flagship GenomeQuest service to PIPRA PIPRA will use it to develop comphrehensive patent landscapes surrounding agricultural biotechnologies (3/7)
Eden Bioscience Corp. (EDEN) Plant Health Care Inc. PHC is purchasing Eden's harpin protein technology and and assets related to agricultural and horticultural markets Eden gets $1.5M in cash up front and $1M in the form of a promissory note; Eden kept rights in the home and garden market (12/4); completed the sale (3/1)
Evolutec Group plc (UK; LSE:EVC) Merial Ltd.* Option agreement covering the animal health uses of Evolutec's vaccine technology The agreement grants Merial a 12-month option to acquire exclusive worldwide rights to Evolutec's vaccine technology to animal health uses in return for licensing and milestone fees and a royalty on sales (3/20)
IGI Inc. (AMEX:IG) Novavax Inc. (NVAX) Novavax got rights from IGI that will allow it to expand its alliance with Bharat Biotech International Ltd. of India Under the deal, Bharat gained rights to develop certain vaccines for animals in India and certain other markets using Novasomes adjuvant technology; IG and Novavax would share any resulting royalties (1/5)
Integrated Genomics Inc.* TMO Renewables Ltd.* (UK) Licensing agreement for the ERGO bioinformatics software developed and maintained by Integrated Genomics It will be used to further understand and exploit TMO's thermophilic strains to deliver green biofuels (5/22)
Keygene NV*(the Netherlands) D1 Oils plc (UK; LSE:DOO) Agreement for molecular genetics research in Jatropha curcas, an oilseed tree that grows in tropical and sub-tropical regions and produces high yields of inedible vegetable oil that can be refined into high-quality biodiesel The two-year deal provides D1 with exclusive rights on applied contract research and molecular services carried out by Keygene (9/28)
Mendel Biotechnology Inc.* Tinplant Biotechnik und Pflanzenver-mehrung GmbH(Germany) Mendel acquired a Miscanthus breeding program from Tinplant Miscanthus is one of the leading candidate crops for the production of lignocellulosic plant material to create biofuels such as ethanol (3/30)
Mendel Biotechnology Inc.* BP (UK) Collaboration to develop biofeedstocks for the production of cellulosic biofuels BP will become a shareholder of Mendel, with representation on Mendel's board (6/13)
MetaMorphix Inc.* Hubbard SAS (unit of La Corbiere SA; France) Alliance to jointly develop a set of genomic markers for use in genetic programs at Hubbard They will use MetaMorphix technologies to develop predictive genetic markers for desired broiler performance traits; Meta-morphix is entitled to royalties on revenues generated from the new breeds (1/29)
Scynexis Inc.* Merial Ltd.* Expanded research collaboration, increasing the capacity of their biological screening, bioanalytical, ADMET and medicinal chemistry efforts directed toward Merial's animal health projects Financial terms were not disclosed (5/15)
Senesco Inc. (AMEX:SNT) Bayer CropScience Technologies AG (Germany) Agreement for exclusive rights to Senesco's gene technology to enhance cotton fiber and seed yields in its FiberMax brand on a global basis Senesco is entitled to milestones and royalty payments (7/24)
Senesco Technologies Inc. (AMEX:SNT) Bayer CropScience AG (Germany) Exclusive worldwide rights agreement for gene technology for use in rice Senesco is entitled to development milestone payments and royalties on resulting sales (9/18)
Senesco Technologies

Inc. (AMEX:SNT)

 Monsanto Co. (NYSE:MON) License agreement to use Senesco's yield and stress technology in corn and soybean production Financial terms were not disclosed (8/9)
Solazyme Inc.* Imperium Renewables Inc.* Biodiesel feedstock development agreement Solazyme will generate algal oil for Imperium's biodiesel production process; Solazyme will grow its strains of micro-algae, extract the oil and deliver it to Imperium (6/6)
Syngenta Seeds Inc. (NYSE:SYT) BioTrove Inc.* Agreement under which BioTrove will supply genomics technology to accelerate Syngenta's research and development and breeding programs across all its seeds businesses Syngenta gains access to the OpenArray system, which is used for conducting genotyping analyses in a microarray format (5/8)
Tissue Genesis Inc.* Vet-Stem Inc.* Exclusive distribution and licensing agreement for the veterinary market Tissue Genesis is entitled to equity in Vet-Stem and royalties under the agreement; it expects to later receive revenue from sales to Vet-Stem of TGI 1000 cell isolation systems, TGI 1000 disposables and TGI 100 kits (6/22)
Uluru Inc. (OTC BB:ULUR) Unnamed veterinary company Agreement to evaluate the delivery of drugs to companion animals using its patented mucoadhesive erodible film technology The partner will assume the costs of feasibility testing (7/18)
Velcera Inc.* Novartis Animal Health (Switzerland) Global licensing agreement for Novartis to develop, register and commercialize a canine product using Velcera's oral mucosal drug delivery technology, Promist The deal calls for up-front payments, milestone payments and royalties based upon Novartis sales (6/7)
Notes:

This chart contains information on new and revised corporate agreements, as well as other actions, involving agricultural or animal biotechnology.

* Private companies are indicated with an asterisk.

Unless otherwise indicated, shares are traded on the Nasdaq exchange.

AMEX = American Stock Exchange; LSE = London Stock Exchange; NYSE = New York Stock Exchange; OTC BB = Over-the-Counter Bulletin Board; TASE = Tel Aviv Stock Exchange.